Search Results 481-490 of 17091 for pharmacogenetics
The purpose of this study is to Identify baseline and early treatment genetic, molecular, and cellular drivers of 4-month endoscopic response to anti-IL-23, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to elicit clinicians' and scientists' views, ethical concerns, clinical aspirations and governance needs regarding prenatal gene ...
Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as cisplatin ...
The secondary goal is to asses clinical endopoints associated with standard of care therapies for TCR MM, in a real-world setting during 12 months of ...
Rochester, Minn. This is a survey study to describe how women with Lynch syndrome are being screened for gynecologic cancer risk, their perception of cancer ...
The purpose of this study of sulfasalazine is to see how well it works in preventing acute diarrhea in patients with cancer who are undergoing pelvic radiation ...
Pharmacogenetics of OATP Transporters Reveals That SLCO1B1 c. 388A>G Variant Is Determinant of Increased Atorvastatin Response Int J Mol Sci. 2011; 12(9): ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!